In person
Molecular glues and targeted protein degraders are revolutionizing the field of drug discovery, offering promising solutions for a range of diseases, including cancer, infectious, inflammatory, and neurodegenerative diseases. These innovative therapies are particularly beneficial for targeting previously “undruggable” pathogenic proteins. The recent emergence of the ‘molecular glue’ class of protein degraders is paving the way for novel treatments aimed at addressing critical unmet medical needs.
In light of the excitement surrounding this breakthrough, the Society for Medicines Research was organizing a one-day meeting at the GSK Campus in Stevenage, UK, focused on the theme of Molecular Glues. Esteemed speakers from both academia and industry presented the latest advances in the field. Presentations covered a variety of topics, including the discovery of molecular glues, their therapeutic applications, and the cell biology that supports the molecular glue concept.
ZoBio was excited to attend the meeting for the second time. Pim de Vink, our Scientist, presented a lecture titled “Cooperativity: How to Discover Molecular Glues de Novo using Biophysics”, which was very well received.